Cardioscan x9 | Unique Heart Diagnostic Device
cardioscan, x9, cardioscanx9, cardioscan x9, heart, heart diagnosis, heartdiagnosis, heart diagnostic, magnetocardiography, mcg, device, mdical equipment, equipment, healthcare, uk, london, ukraine
14468
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-14468,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,vss_responsive_adv,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
CARDIOSCAN x9

CARDIOSCAN x9


New medical equipment for early, non-invasive diagnosis of heart diseases.
Fast screening - accurate diagnosis - quick verification - choice of treatment strategy.

Pre-order Distribution

ASOLUTELY NEW & UNIQUE EQUIPMENT

CARDIOSCAN X9

Cardioscan fills the gap in heart diagnosis between non-invasive, low-sensitivity conventional diagnostic methods (e.g. electrocardiography-ECG) and invasive (e.g. coronary angiography).

 

It was developed by our team on the basis of 20 years of experience in the development, production and operation of magnetocardiography devices.

NEW FEATURES

SPEED

Fast examination of patient - up to 11 minutes.

SAFETY

Completely safe examination, the device does not emit any waves, it is completely passive.

NON-INVASIVENESS

Non-contact obtaining of information about the body function.

ACCURACY

Exceptionally high accuracy of the formulation of the diagnosis and its verification.

EFFICIENCY

The choice of treatment strategies and predicting outcomes.

UNIQUENESS

The forecast of possible problems in the heart of athletes and socially responsible workers.

INSTALLATION IN UNSHIELDED ROOMS

Does not require very expensive passive shields. Usually in the form of magnetic and electromagnetically shielded rooms (MSR) with walls.

UNIQUE ALGORITHMS FOR DATA PROCESSING

The software is developed on the basis of clinical data from over 5000 patients.

AUTOMATED POSITIONING SYSTEM

Adjustable patient bed with unique automatic positioning system.

PRINCIPLE OF OPERATION

DESCRIPTION

The principle of operation is based on recording changes in the magnetic field caused by electrical activity of the heart in cardiac cycles. Cardiac electrical activity (which produces a potential difference on the surface of the body, which leads to an ECG curve) produces simultaneously a magnetic field that extends beyond the human body. MCG signals, in contrast to ECG signals, are not weakened due to the anatomical structure, tissues and body fluid, thus providing more accurate information about eddy currents in the myocardium and producing magnetic signatures that are not visible on the ECG, thereby giving the MCG more information.

 

Maximum sensitivity sensors – Superconductive Quantum Interference Device (SQUID), cooled in cryostat by liquid helium to the temperature of – 269ºC, is capable of detecting changes in a very weak magnetic signal.

 

Application of sophisticated active and passive protection of the detector allows to install equipment even in susceptible to communications disruption rooms. Automatic sliding table for the patient, bundled with fixed detectors, allow to playback electromagnetic maps of electrical activity of heart the size of 20 x 20 cm. Developed method, using SQUID-technology, is highly promising for application in daily clinical practice.

NEW DESIGN

  • cs-6
  • cs-7
  • cs-2
  • cs-3

OUR TEAM

IMG_6665

YEARS OF EXPERIENCE

The development of magnetocardiography equipment was carried out by our team since 1997.

 

Currently in Western & Eastern Europe and Asia successfully operates 11 units of previous generations of MCG equipment, which was created and developed by our team. During this period, there was no equipment malfunction or failure of our system. We are proud of our intellectual potential, which is embodied in the decisions which are used now in world’s leading cardio clinics.

 

On the one hand, our team includes scientific employees, technical specialists in MCG equipment and developers of unique software, whose focus is a continuous improvement of Cardioscan. On the other hand, team consists of doctors of medicine and medical staff with great practical experience in magnetocardiography. They are able to organize training of medical personnel for our customers.

TESTIMONIALS

  • “Modern trends in cardiology urgently require the development of new non-invasive methods for diagnosing the functioning of the heart."


    Dr. Friedrich Steinberg
    (SQUID AG, Germany)

  • "MCG technology has a great market potential."


    Prof. Bernd Schwabe
    (Margarethe von Wrangell innovation fund)

  • “The combination of MCG and ECG methods is a promising direction for further research, which can lead to valuable practical results”.


    Dr. Peter van Leeuwen
    (Grönemeyer Institute of MicroTherapy)

  • “The proposed new non-invasive diagnostic technology can improve the risk assessment for ischemic heart disease (IHD) after myocardial infarction”.


    Prof. Gerhard Stroink
    (Dalhousie University, Halifax, Canada)

  • "New research in this direction will make a significant contribution to the technique of non-invasive diagnostics in cardiology, especially in difficult clinical cases for diagnosis”.


    Prof. Patrick Neree
    (University of Regina)

  • “The combination of ECG and MCG signals provides an opportunity to get more complete information about the processes in the myocardium and on tissue level”.


    Dr. Olga Zakhrabova
    (Academic Medical Center, Amsterdam University)

  • “Current experience in the field of MCG shows the possibility of providing slices of electrical information in various planes at certain depths on the surface of the frontal plane".


    Prof. Paul Guggenholz
    (Erasmus University, Rotterdam)

  • “As opposed to the standard ECG, magnetic field mapping can provide better information on early structural and functional changes in the heart”.


    Dr. Georg Tudor
    (University of Ottawa)

  • “Synchronous registration of magnetic cardiography (MCG) and electrocardiography (ECG) and combined data processing can provide new opportunities for early and accurate diagnosis and monitoring of heart diseases”.


    Prof. Alexander Shirdevan
    (Charité, Berlin)

  • "Informativeness of MCG exceeds informativeness of ECG, thus forming the basis for the introduction of MCG in clinical practice to save the lives of millions of people and reduce the losses from this menacing pathology."


    Dr. Peter Kohl
    (British Heart Foundation)

Right now you can place a pre-order for CARDIOSCAN x9!
Just fill out the application or contact us directly!